Correction: First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-10-01
Series:	Lupus Science and Medicine
Online Access:	https://lupus.bmj.com/content/7/1/e000354corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study
by: Viktoria Hermann, et al.
Published: (2019-12-01)

Relieving acute pain (RAP) study: a proof-of-concept protocol for a randomised, double-blind, placebo-controlled trial
by: Thomas Scalea, et al.
Published: (2019-11-01)

Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial
by: Richard A Furie, et al.
Published: (2020-10-01)

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
by: Majed Al-Jeraisy, et al.
Published: (2021-04-01)

High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study
by: Ashim Das, et al.
Published: (2019-08-01)

Correction: Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study.
by: Carlos César Lopes de Jesus, et al.
Published: (2024-01-01)

The role of Ashwagandha in modulating gut parameters in dogs—a randomized double-blind placebo-controlled trial
by: Kala Kumar Bharani, et al.
Published: (2025-01-01)

Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trialResearch in context
by: Katrine Lundby Høyer, et al.
Published: (2025-01-01)

MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty – protocol for a double-blind, randomised controlled proof-of-concept trial
by: Andrew Clegg, et al.
Published: (2022-07-01)

Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
Published: (2025-01-01)

Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption
by: Tina Vilsbøll, et al.
Published: (2021-02-01)

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial
by: Torben Hansen, et al.
Published: (2018-10-01)

Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial
by: Torben Hansen, et al.
Published: (2020-01-01)

Protocol for a prospective double-blind, randomised, placebo-controlled feasibility trial of octreotide infusion during liver transplantation
by: Gareth Ambler, et al.
Published: (2021-12-01)

Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study
by: Yoshiya Tanaka, et al.
Published: (2016-07-01)

Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial
by: Ana Licina, et al.
Published: (2019-08-01)

Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
by: Hamida Turki, et al.
Published: (2021-03-01)

Local Vibratory Stimulation for Temporomandibular Disorder Myofascial Pain Treatment: A Randomised, Double-Blind, Placebo-Controlled Preliminary Study
by: Emanuela Serritella, et al.
Published: (2020-01-01)

Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial
by: Ardalan H Zolnourian, et al.
Published: (2020-03-01)

Protocol of the study: the effectiveness of pleuran in the treatment of acute gastroenteritis in children—a randomised, placebo-controlled, double-blind trial (EPTAGE)
by: Katarzyna Wzorek-Łyczko, et al.
Published: (2021-03-01)

IRIS, a randomised, double-blind, placebo-controlled trial of interleukin-6 receptor inhibition undergoing endovascular treatment in acute anterior circulation ischaemic stroke: study rationale and design
by: Xunming Ji, et al.

The effects of AG1® supplementation on the gut microbiome of healthy adults: a randomized, double-blind, placebo-controlled clinical trial
by: Michael B. La Monica, et al.
Published: (2024-12-01)

Correction: Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial
Published: (2020-03-01)

Actions of annatto-extracted tocotrienol supplementation on obese postmenopausal women: study protocol for a double-blinded, placebo-controlled, randomised trial
by: Rui Wang, et al.
Published: (2020-03-01)

Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study
by: Susan Ball, et al.
Published: (2019-10-01)

FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder
by: Li Ling, et al.
Published: (2022-01-01)

Thymosin alpha 1 in the prevention of infected pancreatic necrosis following acute necrotising pancreatitis (TRACE trial): protocol of a multicentre, randomised, double-blind, placebo-controlled, parallel-group trial
by: Tao Chen, et al.
Published: (2020-09-01)

Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study
by: Ramakrishna Nirogi, et al.
Published: (2022-01-01)

Targeting Toll-Like Receptors for Treatment of SLE
by: Christopher G. Horton, et al.
Published: (2010-01-01)

Adaptogenic Ashwagandha root extract modulates inflammatory markers in feline stress management: a double-blind placebo-controlled clinical trial
by: Ashok Kumar Devarasetti, et al.
Published: (2024-12-01)

Bismuth-Based Triple Therapy with Bismuth Subcitrate, Metronidazole and Tetracycline in the Eradication of Helicobacter pylori: A Randomised, Placebo Controlled, Double-Blind Study
by: Sander Veldhuyzen van Zanten, et al.
Published: (2000-01-01)

Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol
by: Simon Bond, et al.
Published: (2020-11-01)

TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis
by: Tamera J Corte, et al.
Published: (2021-01-01)

Evaluation of the Efficacy of Methylene Blue Administration in SARS-CoV-2-Affected Patients: A Proof-of-Concept Phase 2, Randomized, Placebo-Controlled, Single-Blind Clinical Trial
by: Beatrice Barda, et al.
Published: (2024-10-01)

Anakinra for dengue patients with hyperinflammation: protocol for a randomized double-blind placebo-controlled trial [version 1; peer review: 1 approved, 2 approved with reservations]
by: Angela McBride, et al.
Published: (2024-11-01)

Investigating the effect of verapamil on preservation of beta-cell function in adults with newly diagnosed type 1 diabetes mellitus (Ver-A-T1D): protocol for a randomised, double-blind, placebo-controlled, parallel-group, multicentre trial
by: Piotr Jaroslaw Chmura, et al.
Published: (2024-11-01)

Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen
by: Michael L. McCaleb, et al.
Published: (2025-03-01)

Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
by: Berenice Moreno-Cruz, et al.
Published: (2012-01-01)

Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial
by: Allen C Cheng, et al.
Published: (2019-11-01)

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial
by: Kelly L Bertram, et al.
Published: (2021-12-01)

Correction: First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study

Similar Items

Similar Items